Acupoint Injection of Autologous Stromal Vascular Fraction and Allogeneic Adipose-Derived Stem Cells to Treat Hip Dysplasia in Dogs
Table 2
Clinical outcomes regarding range of motion, lameness, and pain on manipulation on days 7, 15, and 30 after treatment with adipose-derived stem cells (ASCs, dogs numbers from 1 to 5) or autologous stromal vascular fraction (SVF, dogs numbers from 6 to 9).
Day
Dogs numbers 1–5 (ASCs)
Dogs numbers 6–9 (SVF)
7
Clear improvement in three patients (numbers from 2 to 4), particularly in pain on manipulation.
Clear improvement in all patients.
15
Improvement in four patients (numbers from 1 to 4).
Improvement maintained or increased in all patients.
30
Improvement maintained in four patients (numbers from 1 to 4).
